Truncated versions of the c-myb proto-oncogene are transduced by two independent isolates of defective chicken leukemia viruses called AMV and E26 (Wol, 1996; Ganter and Lipsick, 1999) . Moreover, avian leukosis viruses cause B cell lymphomas by proviral integration within, or close to the c-myb locus (Kanter et al., 1988; Pizer and Humphries, 1989; Jiang et al., 1997) . Similar to the situation in birds, activation of cMyb by retroviral insertion has been observed in mice. Injection of moloney murine leukemia virus (MMuLV) in pristane-treated BALB/c mice leads to the development of myeloid leukemia (M-MuLV-induced myeloid leukemia or MML) with a promonocytic phenotype. In virtually all tumors proviral integrations within the c-myb locus were detected (Shen-Ong and Wol, 1987; Wol et al., 1991; Mukhopadhyaya and Wol, 1992; Nazarov and Wol, 1995) . As a consequence of these retroviral integrations, normal gene expression becomes deregulated due to insertion of viral enhancer sequences. In addition c-Myb protein function is altered as a result of N-and C-terminal truncations. Both alterations contribute to oncogenic conversion of c-Myb (Wol, 1996; Ganter and Lipsick, 1999) .
c-Myb functions as a DNA binding regulator of gene expression. The c-Myb protein is characterized by an N-terminal DNA binding domain consisting of three imperfect repeats (R1, R2 and R3) of approximately 50 amino acids. R2 together with R3 are required for sequence-speci®c DNA binding, whereas the function of R1 is less well understood. R1 has been suggested to increase the anity of c-Myb for DNA Ganter and Lipsick, 1999) and to participate in intramolecular interaction with the Myb C-terminus (Dash et al., 1996) . Thus, the c-Myb Nterminus might be involved in protein interactions that regulate Myb function.
The leukemia virus-transduced v-myb oncogenes encode proteins that are truncated at the N-and Cterminus. Truncations caused by retroviral insertion delete either parts of the N-terminus or, less frequently, the C-terminus of Myb. N-terminal deletions have been found that involve 20, 47 or 71 amino acids (Mukhopadhyaya and Wol, 1992; Pizer et al., 1992; Jiang et al., 1997) . The two larger deletions as well as the deletions found in both v-Myb proteins truncate part of R1. Deletion of only 20 amino acids leaves R1 intact but removes a highly conserved acidic region including protein kinase CK2 phosphorylation sites that have been implicated in regulating Myb function (LuÈ scher et al., 1990; OelgeschlaÈ ger et al., 1995) .
To de®ne functional consequences of N-terminal cMyb truncations, mutants were constructed that express Myb proteins with N-terminal deletions of 20, 47 or 71 amino acids (MybDN20, MybDN47 and MybDN71) according to the Myb alterations observed in MMLs. To determine DNA binding activity, the dierent Myb proteins were transiently expressed in Oncogene (2001) 20, 7420 ± 7424 ã 2001 Nature Publishing Group All rights reserved 0950 ± 9232/01 $15.00 www.nature.com/onc COS-7 cells and the corresponding lysates were subsequently analysed in electrophoretic mobility shift assays (EMSA). In each of the dierent extracts, one dominant complex was detected using the high anity Myb binding site, MRE-A, derived from the mim-1 promoter ( Figure 1a ) (Ness et al., 1989; OelgeschlaÈ ger et al., 1995) . Competition of complex formation by unlabeled MRE-A but less eciently by the binding site mutant MRE-Am shows that the complexes are speci®c. Furthermore the complexes were sensitive to a Myb-speci®c serum (Figure 1a ). Steady-state binding was similar for all four proteins tested. To determine DNA binding anities, constant amounts of extracts from transiently transfected COS-7 cells were incubated with increasing amounts of labeled MRE-A. Bound and free oligonucleotides were separated by EMSA, quanti®ed using a PhosphorImager, and dissociation constants were calculated by Scatchard analysis Krieg et al., 1995) . One example of such an experiment is shown in Figure 1b , and all results summarized in Table 1 . MybDN47 and MybDN71, with deletions of 10 and 34 amino acids of R1, respectively, displayed a threefold reduced DNA binding anity in comparison to c-Myb. In contrast, deletion of the ®rst 20 amino acids in MybDN20 resulted in a twofold increase in DNA binding anity. Thus, the three mutant forms of c-Myb generated by proviral insertion have distinct DNA binding anities.
The dierent DNA binding anities of the mutant Myb proteins analysed above suggested that they might exhibit distinct transactivating activities. This possibility was examined in transient reporter gene assays using a construct containing the mim-1 promoter (Ness et al., 1989) , driving the luciferase reporter gene. The mim-1 gene is one of the best studied Myb targets that contains several Myb binding sites. Titration experiments revealed a close correlation between DNA binding anity and reporter activation. The Myb protein with the highest DNA binding activity, MybDN20, was signi®cantly more ecient in transactivating the mim-1 reporter than c-Myb (Figure 2a ). In contrast, MybDN47 and MybDN71 were slightly less ecient. This is most likely an eect of the distinct DNA binding activities of these proteins since all four Myb proteins were equally well expressed ( Figure 2c ).
Ecient activation of mim-1 requires the cooperative action of c-Myb with NF-M/C/EBPb, a member of the CAAT/enhancer binding protein family of transcription factors Burk et al., 1993) . During the activation of the resident mim-1 gene, the SWI/SNF chromatin remodeling complex is recruited by C/EBPb (Kowenz- Leutz and Leutz, 1999) . Furthermore, the histone acetyltransferase CBP/p300 associates with both transcription factors suggesting that Myb and C/EBP serve as multifunctional platforms to accommodate various chromatin remodeling factors that cooperatively activate myelomonocytic genes (OelgeschlaÈ ger et al., 1996; Mink et al., 1997) . Therefore we compared how NF-M, the chicken orthologue of C/EBPb, cooperates with c-Myb and the N-terminal deletion mutants. As shown in Figure 2b , the three mutant proteins as well as c-Myb cooperated eciently with NF-M, reaching similar levels of maximal stimulation of reporter expression. To further examine The N-terminal deletion mutants MybDN20, MybDN47 and MybDN71 were generated by deleting the appropriate regions of murine c-Myb using PCR. The resulting mutant proteins contained identical sequences at the start of translation compared to wt-c-Myb to ensure equal expression. c-Myb, MybDN20, MybDN47 and MybDN71 were expressed transiently in COS-7 cells and DNA binding analysed in F-buer whole cell lysates using EMSA as described previously . As probe 0.2 ng of 32 P-labeled MRE-A (5'-TCGACACATTATAACGGTTTTTTAGC) derived from the mim-1 promoter (Ness et al., 1989) was used. The reactions were supplemented with Myb-speci®c serum 05 or with a 100-fold excess of either unlabeled MRE-A or MRE-Am (5'-TCGACACATTATCACGGTTTTTTAGC) as indicated. The DNA-protein complexes were separated on a 5% non-denaturing polyacrylamide gel. F: free Probe, Myb: Myb-MRE-A complexes, S: anti-Myb supershifted complexes. (b) To determine binding anities, radiolabeled MRE-A was titrated (0.047, 0.12, 0.17, 0.24, 0.47, 0.71 ng) against a constant amount of COS-7-derived Myb and subjected to EMSA. The amount of complexed and free probe was determined by using a PhosphorImager. As one example an autoradiogram (left panel) and the corresponding Scatchard plot (right panel) for the analysis of MybD47 is shown. For a summary of the determined anities see Table 1 Oncogene Modulation of c-Myb function by its N-terminus M Oelgeschla Èger et al the function of the Myb mutations, we analysed their ability to activate the resident chromosomal mim-1 gene in QT6 ®broblast cells. As expected neither c-Myb nor NF-M alone were able to elicit a strong activation of the endogenous mim-1 gene (Figure 3a) . A robust activation, however, was obtained when c-Myb and NF-M were combined. Similarly, both MybDN20 and MybDN47 cooperated with NF-M as eciently as cMyb to activate resident mim-1 (Figure 3a) . In contrast, the MybDN71 mutant failed to activate the mim-1 gene together with NF-M. As an internal control we monitored expression of the gene 126 which becomes activated by C/EBP (Nakano and Graf, 1992; Kowenz-Leutz et al., 1994) . Gene 126 was induced whenever NF-M was present suggesting that MybDN71 neither prevents NF-M expression nor its function. These ®ndings were corroborated by the analysis of the expression of the mim-1 and lysozyme genes in the macrophage cell line HD11 that expresses endogenous NF-M (Figure 3b ). The lysozyme gene is also activated cooperatively by c-Myb and NF-M . Both genes were activated by c-Myb, MybDN20 and MybDN47, but not by MybDN71. Thus, although MybDN71 activated the mim-1 reporter gene cooperatively with NF-M, no cooperativity was seen on the chromosomal mim-1 and lysozyme genes.
In summary our ®ndings de®ne a new role of the R1 repeat for c-Myb function. R1 is not only aecting DNA binding but is also critical for the regulation of the chromosomal copies of two c-Myb target genes, i.e. mim-1 and lysozyme. Thus the activation of the c-myb locus frequently observed during retroviral-induced leukemia development in mice and birds results in Nterminally truncated Myb proteins that dier in DNA binding, transactivation, and cooperativity with NF-M during activation of resident genes. Dissociation constants measured on MRE-A, a high anity Myb binding site form the mim-1 promoter (Ness et al., 1989. b Chicken Myb(1 ± 198) including the three repeats R1 ± 3 was expressed in E. coli and puri®ed under native conditions (Ebneth et al., 1994) . c Murine c-Myb expressed in HeLa cells from a recombinant vaccinia virus, puri®ed under nondenaturing conditions on Ni 2+ -NTA agarose . Dissociation constants of these proteins have been published previously .
e The dierent Myb proteins were expressed transiently in COS-7 cells. DNA binding was measured in whole cell extracts as described previously . Table 1 ). A function of the N-terminus in c-Myb DNA binding has been suggested before, although no anities were measured (Dini and Lipsick, 1993) . For comparison and as a control, we also determined the anity of AMV-v-Myb to DNA that was even twofold lower than that of MybDN71 (Table 1) . The latter result is in accordance with the ®ndings of others, demonstrating that the mutations in R2 of AMV-v-Myb reduce its ability to bind to DNA (Dini et al., 1995; Brendeford et al., 1997) and all DNA anities were in the range of previously established values (Saikumar et al., 1990; Nomura et al., 1993; Tanikawa et al., 1993; Ording et al., 1994) . The DNA binding anities of various truncated Myb forms correlated well with the transactivation potential in reporter assays (Figure 2a) . Thus, it seems unlikely that the ®rst 71 amino acids contribute to the Mybspeci®c transactivation function. Moreover, in the reporter assays, all Myb proteins cooperated with NF-M to a similar extent (Figure 2b ). In accordance with our previous data , this might be due to a multiplicative eect of corecruiting the CBP/p300 complex to the mim-1 promoter by both, NF-M and Myb. The combined recruitment of CBP/p300 coactivator might compensate for some dierences in DNA binding anities of Myb mutants (OelgeschlaÈ ger et al., 1996; Mink et al., 1997) .
An entirely dierent result was obtained when chromosomal rather than reporter gene expression was examined. In contrast to c-Myb, MybDN20 and MybDN47, the MybDN71 protein failed to cooperate with NF-M in the activation of the resident mim-1 gene (Figure 3) . The observation that the mutants MybDN47 and MybDN71 display similar dissociation constants but entirely dierent functions on endogenous target genes precludes the simple possibility that anity towards DNA determines functional interaction with C/EBPs in resident gene activation assays. This result therefore suggests that the region between amino acids 48 and 71 of murine R1 is important for a chromatin activation step and for the cooperativity seen with Myb and NF-M. We have suggested previously that the binding of the coactivator CBP/ p300 is important for Myb-NF-M cooperativity (OelgeschlaÈ ger et al., 1996) . We tested whether MybDN71, as compared to the other Myb proteins used, shows reduced CBP binding. However no dierence was observed in GST pull down assays and coimmunoprecipitation studies (data not shown). This is in line with the observed ability of MybDN71 to cooperate with NF-M in transient assays (Figure 2b ). Thus further studies will be required to reveal in more detail the molecular role of R1 on chromatin and for the functional interaction between Myb and NF-M.
It has been argued from dierent studies that DNA binding and transactivation of Myb mutants do not correlate with the respective transforming potential (Ganter and Lipsick, 1999) . This debate is supported and extended by our ®ndings. Our data demonstrate that activation of endogenous genes in conjunction with NF-M also fails to correlate with leukemogenesis. It even appears that there is an inverse correlation between collaboration with C/EBP and leukemogenicity. All the experiments shown here were performed with Myb mutants that possess an engineered, optimized AUG start codon that ensures equal expression (Figure 2c) . However, the tumor-derived MybDN47 and MybDN71 are fusion proteins that contain viral derived gag sequences at the N-terminus (Mukhopadhyaya and Wol, 1992) . Furthermore, MybDN20 starts from the ®rst internal AUG in cMyb which is in a poor Kozak consensus sequence (Kozak, 1991) . As a result, there is up to 20-fold reduction in protein expression levels compared to wt c-Myb (data not shown) suggesting that if collaboration with C/EBPs occurs, then it is constrained to a low-level by limiting concentrations of Myb. This notion is in accordance with several observations: First, Myb-C/EBP co-regulated genes are correlated to dierentiation rather than to proliferation Kowenz-Leutz et al., 1997) . Second, highly leukemogenic AMV-Myb, which entirely fails to collaborate with C/EBP in resident gene activation (Kowenz-Leutz et al., 1997) , is strongly expressed in leukemic cells Kowenz-Leutz et al., 1997) . Finally, distinct back mutations in AMV-Myb Figure 3 Transactivation of the endogenous mim-1 gene by cMyb and Myb mutants. (a) QT6 cells (quail ®broblast) were transiently transfected with expression plasmids coding for c-Myb (3 mg), MybDN20 (3 mg), MybDN47 (3 mg), MybDN71 (3 mg), and NF-M (3 mg) as described previously (Katz et al., 1993; Kowenz-Leutz et al., 1994) . mRNA was isolated from the transfected cells and analysed by Northern blotting using a probe speci®c for mim-1 (upper panel), gene 126 (middle panel) and GAPDH (lower panel). Mim-1 is regulated by both NF-M and cMyb whereas gene 126 is only NF-M responsive (Kowenz-Leutz et al., 1994) . (b) HD11 cells (chicken macrophage) were transiently transfected with the indicated Myb expression plasmids (8 mg) as described previously (Kowenz-Leutz et al., 1997) . The expression of mim-1 and lysozyme was analysed as described in (a) towards the wildtype con®guration which reduce leukemogenicity (Introna et al., 1990) , partially restore NF-M cooperativity (Kowenz-Leutz et al., 1997; Kowenz-Leutz and Leutz unpublished) .
